The Hanarth fonds granted a project proposal of Cancer Center Amsterdam researcher Martijn van Oijen. The aim of his project is to develop and evaluate practical clinical decision tools created by artificial intelligence (AI) for patients with cancer of unknown primary (CUP) based on the study of metastatic patterns, augmented by regular biomarker information.
The researchers will use data from the nationwide database with pathology outcomes (PALGA), and machine learning and natural language processing algorithms to identify metastatic patterns from patients with a known primary tumor in order to provide insights for patients with cancer of unknown primary.
Principle investigators of this study are Prof. Dr. Iris Nagtegaal (Radboud UMC) & Dr. Martijn van Oijen (Amsterdam UMC)
In close collaboration with PacMed, Amsterdam.